HCA, Tenet, Community Health Downgraded by Raymond James
Demystifying Tenet Healthcare: Insights From 13 Analyst Reviews
Tenet Healthcare Analyst Ratings
Raymond James Downgrades Tenet Healthcare to Outperform From Strong Buy
Raymond James Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $195
Tenet Healthcare Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2016 -- Data Talk
Tenet Healthcare Corporation (THC) Is Attracting Investor Attention: Here Is What You Should Know
Dr. Oz's CMS Nomination Sparks Mixed Reaction From Healthcare Investors -- WSJ
Tenet Healthcare Partners With Commure for Ambient AI Platform
Jefferies Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $200
Tenet Healthcare (THC) Receives a Buy From Jefferies
Larry Robbins' Strategic Moves in Q3 2024: A Deep Dive Into Tenet Healthcare's Significant Reduction
Zacks.com Featured Highlights Include Sterling, Leidos, Tenet Healthcare and Amazon
Pick These 4 Stocks With Solid Interest Coverage Ratio
Tenet Healthcare To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET
13 Cheap Small/mid-cap Buy-rated Stocks With Higher Beta
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Can Tenet Healthcare Corporation's (NYSE:THC) ROE Continue To Surpass The Industry Average?
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $190
Tenet Healthcare Price Target Raised to $190 From $171 at Barclays